openPR Logo
Press release

Cerebral Spinal Fluid (CSF) Management Market Will Witness Growth Based On Rising Incidence Of Chronic CNS Associated Disorders Such As Stroke Till 2022: Grand View Research, Inc.

02-28-2017 09:05 AM CET | Health & Medicine

Press release from: Grand View Research, Inc.

Cerebral Spinal Fluid (CSF) Management Market Will Witness

The global cerebral spinal fluid (CSF) management market is anticipated to reach USD 1.4 billion by 2022, according to a new report by Grand View Research, Inc. Constant evaluation of various techniques by neurosurgeons for improvement of hydrocephalus management is expected to drive growth in this market. Moreover, shunt manufacturers are engaged in the investment for development of novel and improved shunts in order to tackle the pitfalls associated with the existing designs.
Significant increase in geriatric population across the globe as well as raise in incidence of chronic CNS associated disorders such as stroke can be attributed to projected growth. Furthermore, grants for research in neuromodulation therapies in order to develop different products for prognosis of various nervous system associated disorders are expected to boost development.

Browse full research report on Global Cerebral Spinal Fluid (CSF) Management Market:(http://www.grandviewresearch.com/industry-analysis/csf-management-market-analysis-market?utm_source=referral&utm_campaign=Snehali_feb&utm_medium=press%20release)

Further Key Findings from the Study Suggest:
• CSF management devices are expected to witness extensive competition owing to presence of several market players operating in this segment. Rise in number of CSF associated disorders such as trauma and stroke are anticipated to boost demand for these products in the coming years.
• CSF shunts captured the largest market share in terms of revenue generation in 2014.
• These devices are most commonly used for supplementing and replacing lost drainage capacity in case of CSF leak management.
• CSF drainage is anticipated to witness lucrative growth over the forecast period.
• This growth can be attributed to ongoing development for enhancing overall safety of guidance-based systems and anti-biotic impregnated catheters incorporation.
• In 2014, North America accounted for the largest share with respect to revenue generation.
• Factors contributive for the share include continuous increase in the number of Americans affected from Hydrocephalus coupled with ongoing research in neuroscience.
• Asia Pacific is expected to propel with fastest CAGR owing to constantly improving healthcare system in the region.
• Moreover, economic progress of Asia Pacific countries such as China has led to significant transformation of neurology and neurologic practices in the country. This is one of the key drivers to propel progress in this region in the coming years.
• Some of the key players operating in the market include Johnson & Johnson Services, Inc; B.Braun Melsungen AG; Magstim; Elekta AB; Medtronic, Inc.; Integra LifeSciences Corporation;Phoenix Biomedical Corp.; Sophysa; Spiegelberg GmbH & Co. KG; and Beckersmith Medical, Inc.
• These players are engaged in development of novel platforms for CSF management.

Grand View Research has segmented the CSF management market on the basis of products and region:
CSF Management Product Outlook (Revenue, USD Million, 2012 - 2022)
• CSF shunts
• CSF drainage
CSF Management Regional Outlook (Revenue, USD Million, 2012 - 2022)
• North America
• Europe
• Asia Pacific
• RoW

For more information: www.grandviewresearch.com

About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Press Contact
Sherry James - Corporate Relations Specialist
28 2nd Street, Suite 3036
San Francisco, CA 94105
United States
Phone: 1-415-349-0058
Email: sales@grandviewresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Cerebral Spinal Fluid (CSF) Management Market Will Witness Growth Based On Rising Incidence Of Chronic CNS Associated Disorders Such As Stroke Till 2022: Grand View Research, Inc. here

News-ID: 450020 • Views:

More Releases from Grand View Research, Inc.

Generative AI Market Size, Share, And Industry Outlook Report, 2030
Generative AI Market Size, Share, And Industry Outlook Report, 2030
Generative AI Market Growth & Trends The global generative AI market size is anticipated to reach USD 109.37 billion by 2030, according to a new report by Grand View Research, Inc., registering a CAGR of 37.6% from 2025 to 2030. Growing demand to modernize workflow across industries is expected to drive the demand for generative AI applications among industries. Other factors that propel the market growth include the evolution of AI
Maternal Mental Health Market To Reach $45.72 Billion By 2030 | Therapy Mama, Canopie, Pfizer, Inc., Viatris, Inc.
Maternal Mental Health Market To Reach $45.72 Billion By 2030 | Therapy Mama, Ca …
The global maternal mental health market size is expected to reach USD 45.72 billion by 2030, growing at a CAGR of 28.43%, according to a new report by Grand View Research, Inc. Maternal mental health issues are a global concern that affects women of various countries and cultures. It refers to the emotional well-being of women during the pregnancy and postpartum period. The market is driven by the increasing incidence
Downstream Processing Market Size, Share & Trends Analysis Report, 2030
Downstream Processing Market Size, Share & Trends Analysis Report, 2030
The global downstream processing market size is expected to reach USD 94.79 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 14.84% from 2023 to 2030. The capacity requirements during the development of biologic drugs have changed over the past few years, wherein the demand for manufacturing high-volume products has shifted to developing small-volume, high-potency
Electric Mobility Industry: E- Light Commercial Vehicle Thereby Contributing To Creating New Growth Opportunity
Electric Mobility Industry: E- Light Commercial Vehicle Thereby Contributing To …
The global electric mobility industry size stood at USD 101.67 billion in 2022 and will exhibit a CAGR of 19.9% from 2023 to 2030, according to the "Electric Mobility Industry Data Book, 2023 - 2030," published by Grand View Research. The growth comes on the back of an exponential rise in smart cities and a gradual uptick in charging infrastructure. Further, the strong outlook of electric mobility will rely on the launch

All 4 Releases


More Releases for CSF

G Csf And G Csf Biosimilars Market Size Trends and Forecast by Application, Type …
USA, New Jersey- According to Market Research Intellect, the global G Csf And G Csf Biosimilars market in the Internet, Communication and Technology category is projected to witness significant growth from 2025 to 2032. Market dynamics, technological advancements, and evolving consumer demand are expected to drive expansion during this period. The G-CSF and G-CSF biosimilars market is witnessing steady growth, largely due to increasing demand for affordable treatments for neutropenia, especially
G-CSF & G-CSF Biosimilars Market Growth 2032: Increasing Cancer Treatment Demand …
The global market for Granulocyte Colony Stimulating Factor (G-CSF) and G-CSF biosimilars is on a promising growth trajectory as the demand for cost-effective and therapeutic alternatives to branded drugs increases. G-CSF and its biosimilars are vital in treating neutropenia, leukopenia, platelet disorders, and various types of cancer, and their growing adoption is fueled by technological advancements and supportive government policies. The market size was valued at $5.89 billion USD in 2023
G-CSF and G-CSF Biosimilars Market Size, Growth and Forecast 2021 to 2028 By Ame …
The worldwide G-CSF and G-CSF Biosimilars market report is the very much investigated answer for the chiefs and academicians who are looking for a definite examination regarding both subjective just as quantitative, for the notable time frame and for the impending years gauge. The exploration report includes the business outline alongside the approaching dangers and supporting components that will drive or hamper the market development and give open doors sooner
G-CSF and G-CSF Biosimilars Market Size to Witness Huge Growth by 2027: Pfizer, …
G-CSF and G-CSF Biosimilars market Research Report LOS ANGELES, United States: QY Research offers an overarching research and analysis-based study on, “Global G-CSF and G-CSF Biosimilars Market Report, History and Forecast 2016-2027, Breakdown Data by Manufacturers, Key Regions, Types and Application“. This report offers an insightful take on the drivers and restraints present in the market. G-CSF and G-CSF Biosimilars data reports also provide a 5 year pre-historic and forecast
Global G-CSF And G-CSF Biosimilars Market 2025| By Top Key Players Pfizer, Novar …
G-CSF, which is also known as filgrastim, is a growth factor used to aid the recovery of bone marrow after chemotherapy treatment for cancer, especially in patients with neutropenia (low white blood cell count in the blood), which causes reduced resistance to infections. It can also be used to stimulate mobilization of haematopoietic stem cells for collection and transplantation. Request Sample Copy of Report @ https://www.researchtrades.com/request-sample/1664081 This report studies
China CSF Management Market Outlook to 2023
New report, "China CSF Management Market Outlook to 2023", provides key market data on theChina CSF Management market. The report provides value, in millions of US dollars, volume (in units) and and average prices (USD) within market segments - Hydrocephalus Shunts and Dura Substitutes. The report also provides company shares and distribution shares data for each of these market segments, and global corporate-level profiles of the key market participants. Based on